Statistics

Views

Abstract: 4245

PDF (English): 1901

PDF (Russian): 1404

Cited-by

CrossRef: 41

  1. Hara MA, Ramadan M, Abdelhameid MK, Taher ES, Mohamed KO. Pyroptosis and chemical classification of pyroptotic agents. Molecular Diversity. 2025;29(3):2765. doi: 10.1007/s11030-024-10987-6
  2. Zhang C, Tan Y, Huang J, Tang X, Xiang H, Shen B, et al. Engineering nanoliposomes to enhance cancer immunotherapy by reversing immunosuppression and synergistically boosting tumour immunogenicity. Materials & Design. 2023;233:112202. doi: 10.1016/j.matdes.2023.112202
  3. Liu T, Yao W, Sun W, Yuan Y, Liu C, Liu X, et al. Components, Formulations, Deliveries, and Combinations of Tumor Vaccines. ACS Nano. 2024;18(29):18801. doi: 10.1021/acsnano.4c05065
  4. Dutra MJ, Malta IS, Lança M, Vasconcellos L, Adorno-Farias D, Jara JA, et al. Effects of artemisinin and cisplatin on the malignant progression of oral leukoplakia. In vitro and in vivo study. Journal of Cancer Research and Clinical Oncology. 2024;150(8). doi: 10.1007/s00432-024-05924-x
  5. Moini K, Seery T, Nangia C, MacDiarmid J, Brahmbhatt H, Spilman P, et al. Recurrent pancreatic cancer treated with N-803 and PD-L1 t-haNK followed by an EGFR-targeted nanocell drug conjugate. The Oncologist. 2025;30(3). doi: 10.1093/oncolo/oyae267
  6. Souiade L, Rodriguez-Garcia M, Serrano-Olmedo J, Ramos-Gómez M. Pulsed Alternating Fields Magnetic Hyperthermia in Combination with Chemotherapy (5-Fluorouracil) as a Cancer Treatment for Glioblastoma Multiform: An In Vitro Study. Nanomaterials. 2025;15(7):556. doi: 10.3390/nano15070556
  7. Niu N, Li K, Wang J, Funes V, Espinoza B, Li P, et al. Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancreatic cancer. Biomarker Research. 2025;13(1). doi: 10.1186/s40364-024-00721-7
  8. Engelen Y, Demuynck R, Ramon J, Breckpot K, Smedt SD, Lajoinie G, et al. Immunogenic cell death as interplay between physical anticancer modalities and immunotherapy. Journal of Controlled Release. 2025;384:113721. doi: 10.1016/j.jconrel.2025.113721
  9. Dykman LA, Staroverov SA, Vyrshchikov RD, Fursova KK, Brovko FA, Soldatov DA, et al. Preparation of Phage Antibodies to Heat Shock Proteins and Studying the Dynamics of their Accumulation in Mice with Xenotransplant Tumors. Applied Biochemistry and Microbiology. 2023;59(4):539. doi: 10.1134/S0003683823040051
  10. Lou H, Shang X, Wang Z, Xiang S, Qiu Y, Wang C, et al. Chitosan-derived drug free “artificial beacon” simulating immunogenetic cell death cascade effector to initiate immune response for cancer therapy. International Journal of Biological Macromolecules. 2025;287:138434. doi: 10.1016/j.ijbiomac.2024.138434
  11. Liao X, Liu H, Zhang Z, Zhang J, Zhang C, Zhao W. An immunogenic cell death-associated classification predictions are important for breast invasive carcinoma prognosis and immunotherapy. Frontiers in Genetics. 2022;13. doi: 10.3389/fgene.2022.1010787
  12. Nakajima K, Ogawa M. Near-infrared photoimmunotherapy and anti-cancer immunity. International Immunology. 2024;36(2):57. doi: 10.1093/intimm/dxad042
  13. Amiri M, Jafari S, Lavasanifar A, Molavi O, Montazersaheb S. Nano-delivery of Silibinin Potentiate the Induction of Immunogenic Cell Death (ICD) in Melanoma Cells. Current Pharmaceutical Biotechnology. 2025;26(3):392. doi: 10.2174/0113892010280336240227062954
  14. Yan M, Peng J, Wu H, Ma M, Zhang Y. Injectable Magnetic-Nanozyme Based Thermosensitive Hydrogel for Multimodal DLBCL Therapy. Gels. 2025;11(3):218. doi: 10.3390/gels11030218
  15. Engelen Y, Krysko DV, Effimova I, Breckpot K, Versluis M, Smedt SD, et al. Optimizing high-intensity focused ultrasound-induced immunogenic cell-death using passive cavitation mapping as a monitoring tool. Journal of Controlled Release. 2024;375:389. doi: 10.1016/j.jconrel.2024.09.016
  16. Sprooten J, Laureano RS, Vanmeerbeek I, Govaerts J, Naulaerts S, Borras DM, et al. Trial watch: chemotherapy-induced immunogenic cell death in oncology. OncoImmunology. 2023;12(1). doi: 10.1080/2162402X.2023.2219591
  17. Guliy OI, Staroverov SA, Dykman LA. Heat Shock Proteins in Cancer Diagnostics. Applied Biochemistry and Microbiology. 2023;59(4):395. doi: 10.1134/S0003683823040063
  18. Yan Z, Liu Z, Zhang H, Guan X, Xu H, Zhang J, et al. Current trends in gas-synergized phototherapy for improved antitumor theranostics. Acta Biomaterialia. 2024;174:1. doi: 10.1016/j.actbio.2023.12.012
  19. Abramovich M, Zaikina P, Barskaya E, Beloglazkina E. Synthesis and biological properties of small molecules — ligands of non-canonical DNA and RNA structures. Russian Chemical Reviews. 2024;93(9):RCR5134. doi: 10.59761/RCR5134
  20. Wang Y, Zhou J, Dong Y, Wang P, Zi R, Zhang H, et al. A smart-responsive Y-shaped DNA scaffold drug conjugate achieving precise and synergetic tumor chemo-gene therapy via promoting tumor apoptosis and activating the anti-tumor immunity. Chemical Engineering Journal. 2024;500:157036. doi: 10.1016/j.cej.2024.157036
  21. Troitskaya O, Novak D, Varlamov M, Biryukov M, Nushtaeva A, Kochneva G, et al. Immunological Effects of Cold Atmospheric Plasma-Treated Cells in Comparison with Those of Cells Treated with Lactaptin-Based Anticancer Drugs. Biophysica. 2022;2(3):266. doi: 10.3390/biophysica2030025
  22. Guliy OI, Staroverov SA, Dykman LA. Heat Shock Proteins in Сancer Diagnostics. Прикладная биохимия и микробиология. 2023;59(4):323. doi: 10.31857/S0555109923040062
  23. Lv J, Cai J, Yuan K, Wang J, Xu Y, Huang X, et al. Immunogenic cell death inducers:Current advances and future perspectives. Coordination Chemistry Reviews. 2025;542:216846. doi: 10.1016/j.ccr.2025.216846
  24. Chakraborty S, Sen U, Ventura K, Jethalia V, Coleman C, Sridhar S, et al. Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer. Cell Reports Medicine. 2024;5(12):101852. doi: 10.1016/j.xcrm.2024.101852
  25. Wang H, Xia R, Chang W, Hsu S, Wu C, Chen C, et al. Improving cancer immunotherapy in prostate cancer by modulating T cell function through targeting the galectin-1. Frontiers in Immunology. 2024;15. doi: 10.3389/fimmu.2024.1372956
  26. Chen Y, Shie M, Chang K, Su C, Ho C, Ye S, et al. Novel L-cysteine-functionalized Au@MnO2/MoO3 nanocomposites for electrochemical detection of apoptosis-related proteins in immunogenic cell death of patient-derived lung cancer cells. Sensors and Actuators Reports. 2025;9:100316. doi: 10.1016/j.snr.2025.100316
  27. Boobalasibi S, Kabilan B, Dinesh A, Patil RP, Radhakrishnan K, Gnanasekaran L, et al. Review on Magnetic Nanoparticle-Infused Polymer Nanocomposites for Enhanced Photothermal Performance. Semiconductors. 2024;58(12):1027. doi: 10.1134/S1063782624602115
  28. Sood A, Jothiswaran V, Singh A, Sharma A. Anticancer peptides as novel immunomodulatory therapeutic candidates for cancer treatment. Exploration of Targeted Anti-tumor Therapy. 2024;5(5):1074. doi: 10.37349/etat.2024.00264
  29. He Z, Jing X, Dai X, Bao L, Yang X, Xiong Y, et al. The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma. Frontiers in Bioscience-Landmark. 2024;29(4). doi: 10.31083/j.fbl2904158
  30. Sun G, He L. A new paradigm for cancer immunotherapy: targeting immunogenic cell death-related noncoding RNA. Frontiers in Immunology. 2025;15. doi: 10.3389/fimmu.2024.1498781
  31. Pazoki A, Dadfar S, Shadab A, Haghmorad D, Oksenych V. Soluble CD40 Ligand as a Promising Biomarker in Cancer Diagnosis. Cells. 2024;13(15):1267. doi: 10.3390/cells13151267
  32. Zhang X, Shang C, Qiao X, Guo Y. Role and clinical significance of immunogenic cell death biomarkers in chemoresistance and immunoregulation of head and neck squamous cell carcinoma. Biomedicine & Pharmacotherapy. 2023;167:115509. doi: 10.1016/j.biopha.2023.115509
  33. Collins VG, Hutton D, Hossain-Ibrahim K, Joseph J, Banerjee S. The abscopal effects of sonodynamic therapy in cancer. British Journal of Cancer. 2025;132(5):409. doi: 10.1038/s41416-024-02898-y
  34. Pomi FL, Borgia F, Custurone P, Vaccaro M, Pioggia G, Gangemi S. Role of HMGB1 in Cutaneous Melanoma: State of the Art. International Journal of Molecular Sciences. 2022;23(16):9327. doi: 10.3390/ijms23169327
  35. Xu B, Niu R, Deng R, Tang Y, Wang C, Wang Y. A Cu‐Based Single‐Atom Nanozyme Platform with Multi‐Enzyme Simulated Activities for Immunotherapy of Prostate Cancer by Regulating Cholesterol Metabolism and Triggering Pyroptosis. Advanced Functional Materials. 2024;34(46). doi: 10.1002/adfm.202405265
  36. Hong L, Xu K, Yang M, Zhu L, Chen C, Xu L, et al. VISTA antibody-loaded Fe3O4@TiO2 nanoparticles for sonodynamic therapy-synergistic immune checkpoint therapy of pancreatic cancer. Materials Today Bio. 2024;26:101106. doi: 10.1016/j.mtbio.2024.101106
  37. Xie D, Wang Q, Wu G. Research progress in inducing immunogenic cell death of tumor cells. Frontiers in Immunology. 2022;13. doi: 10.3389/fimmu.2022.1017400
  38. Lu K, Li H, Sun L, Dong X, Fan Y, Dong D, et al. Comprehensive analysis of immunogenic cell death-related genes in liver ischemia-reperfusion injury. Frontiers in Immunology. 2025;16. doi: 10.3389/fimmu.2025.1545185
  39. Biryukov M, Semenov D, Kryachkova N, Polyakova A, Patrakova E, Troitskaya O, et al. The Molecular Basis for Selectivity of the Cytotoxic Response of Lung Adenocarcinoma Cells to Cold Atmospheric Plasma. Biomolecules. 2023;13(11):1672. doi: 10.3390/biom13111672
  40. Dykman LA, Staroverov SA, Vyrshchikov RD, Fursova KK, Brovko FA, Soldatov DA, et al. Preparation of Phage Antibodies to Heat Shock Proteins and Studying the Dynamics of their Accumulation in Mice with Xenotransplant Tumors. Прикладная биохимия и микробиология. 2023;59(4):410. doi: 10.31857/S0555109923040050
  41. Lu J, He R, Liu Y, Zhang J, Xu H, Zhang T, et al. Exploiting cell death and tumor immunity in cancer therapy: challenges and future directions. Frontiers in Cell and Developmental Biology. 2024;12. doi: 10.3389/fcell.2024.1416115

Article Metrics

Metrics Loading ...

Dimensions

PlumX